StratifiCare is a medical device that utilizes severe dengue diagnostics.
StratifiCare has raised $391K in total funding. The most recent round was Grant. The last funding was announced in March 2026.
StratifiCare's investors include ADB Ventures, Sprout Venture Partners, Enterprise Singapore, Jeffrey Tiong, TIS Japan.
StratifiCare is headquartered in Singapore, Singapore.
StratifiCare is a medical device that utilizes severe dengue diagnostics.
StratifiCare is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"StratifiCare — Funding & Investors." VCBacked, March 19, 2026, https://www.vcbacked.co/company/stratificare. Accessed September 30, 2026.
VCBacked. (2026). StratifiCare — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/stratificare
{{cite web |title=StratifiCare — Funding & Investors |url=https://www.vcbacked.co/company/stratificare |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated